Concourse Financial Group Securities, Inc. Beam Therapeutics Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$22.57 - $33.14 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$21.22 - $32.66 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$23.46 - $45.07 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$17.69 - $30.76 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$23.01 - $32.46 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$23.01 - $32.46 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$29.32 - $35.99 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$30.15 - $48.79 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$36.73 - $51.6 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$39.79 - $70.31 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$29.86 - $62.36 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$53.73 - $82.16 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$68.02 - $99.06 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	SELL	$84.37 - $133.6 $8,437 - $13,360	-100 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$19.0 - $30.57 $1,900 - $3,057	100 New	100 $2,000
Q2 2020 Aug 13, 2020	BUY	$15.26 - $28.66 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$13.31 - $29.2 $0 - $0	0 New	0 $0

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

Farallon Capital Management LLC San Francisco, CA

8.21M
Shares

$208 Million
1.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.84M
Shares

$198 Million
0.0% of portfolio
Black Rock Inc. New York, NY

7.63M
Shares

$193 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

6.53M
Shares

$165 Million
1.52% of portfolio
Arch Venture Management, LLC Chicago, IL

4.83M
Shares

$122 Million
71.21% of portfolio

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account